![](/img/cover-not-exists.png)
A phase 2a, open-label pilot study of the galectin-3 inhibitor GR-MD-02 for the treatment of moderate-to-severe plaque psoriasis
Ritchie, Simon, Neal, Danielle, Shlevin, Harold, Allgood, Adam, Traber, PeterVolume:
77
Language:
english
Journal:
Journal of the American Academy of Dermatology
DOI:
10.1016/j.jaad.2017.05.055
Date:
October, 2017
File:
PDF, 763 KB
english, 2017